Finance 21 May 2026

ChampionsGate Stock Little Changed as SPAC Deal Timeline Gets Attention

ChampionsGate Stock Little Changed as SPAC Deal Timeline Gets Attention

ChampionsGate Acquisition Corporation stock was flat in premarket trading Wednesday. The Nasdaq-listed SPAC stayed near the level investors could redeem for cash if the company doesn’t seal a merger. The stock last changed hands at $10.35, off 0.07% in the past 24 hours. TradingView data showed the market shut with no fresh trades on the tape at the time. It had a market cap near $103.4 million.
June 3, 2026
Cipher Digital Stock Is Jumping Again — The AI Power Bet Behind CIFR’s Rally

Cipher Digital Stock Is Jumping Again — The AI Power Bet Behind CIFR’s Rally

Cipher Digital Inc. shares rose 6.4% to $20.73 in Thursday morning trading, extending a volatile run as investors stayed with the company’s shift from bitcoin mining toward AI data-center infrastructure. The Nasdaq-listed stock traded between $19.50 and $21.00, with volume at about 8.5 million shares and market value near $8.4 billion. The move matters now because CIFR was climbing while the broader large-cap tech tape was weaker. The Invesco QQQ Trust, an exchange-traded fund that tracks the Nasdaq 100, was down 0.6%, making Cipher’s move stand out in a soft morning for big tech proxies.
May 21, 2026
Canaan Stock Drops After Q1 Loss Widens — Why CAN Is Under Pressure Now

Canaan Stock Drops After Q1 Loss Widens — Why CAN Is Under Pressure Now

Canaan Inc. shares fell in New York trading on Thursday as investors weighed a wider first-quarter loss, weaker second-quarter revenue guidance and pressure in the bitcoin-mining hardware market. The Nasdaq-listed stock was down about 5.3% at $0.4127 by late morning, after trading between $0.407 and $0.4451. Volume was about 3.8 million shares. Bitcoin was also lower, near $76,900.
May 21, 2026
POM Stock Nears 12 Cents as Nasdaq Deadline for Pomdoctor Gets Focus

POM Stock Nears 12 Cents as Nasdaq Deadline for Pomdoctor Gets Focus

Pomdoctor Limited shares slipped in early Nasdaq trade Thursday. The Chinese digital-health microcap is still working to regain compliance with the $1 minimum bid level on the exchange. The American depositary shares, or ADSs, were last at $0.1153, down $0.0094 from the previous close. Volume showed 172,520 shares traded. Market data put the session low at $0.1153.
May 21, 2026
NCS Multistage Shares Tick Up on Tuesday

NCS Multistage Shares Tick Up on Tuesday

NCS Multistage Holdings, Inc. traded higher early Thursday on Nasdaq. The Houston-based oilfield-services company is lightly traded and shares often move on small volumes, especially after its weaker first-quarter report. The stock traded at $44.10, rising about 1% from Wednesday’s close after hitting the upper end of its morning range. Market cap was around $114.6 million. Other indexes moved lower—Investing.com had the S&P 500 down 0.23% and the Nasdaq off 0.37%. WTI crude futures gained 2.21%.
May 21, 2026
PRCT rises as Wall Street slips; investors look again at Aquablation

PRCT rises as Wall Street slips; investors look again at Aquablation

PROCEPT BioRobotics shares were slightly higher early Thursday, up 18 cents to $28.29. The stock was steadier than much of the medical-device group as Wall Street opened lower again with new jitters over oil and the Middle East. According to Reuters, the Dow, S&P 500 and Nasdaq all slipped at the open. Procept BioRobotics shares barely moved, but even a slight gain is notable for a stock still working to regain trust after a rough guidance cut earlier this year. The company, which most recently was valued around $1.60 billion, has to prove adoption of its Aquablation systems can fuel more consistent procedures, boost consumable sales, and slow its cash burn.
May 21, 2026
Entegris Stock Is Stuck While AI Chip Demand Booms — Here’s What Traders Are Testing

Entegris Stock Is Stuck While AI Chip Demand Booms — Here’s What Traders Are Testing

Entegris shares were nearly flat in early Nasdaq trading on Thursday, lagging sharper gains in some chip-equipment peers as investors weighed the semiconductor materials supplier’s AI-linked growth case against a rich valuation. The stock recently traded at $127.75, up 5 cents, or less than 0.1%, after moving between $125.50 and $128.36. Entegris had a market value of about $19.6 billion at that price.
May 21, 2026
Bright Minds Biosciences Up After $220 Piper Sandler Call—Key Level for DRUG Traders

Bright Minds Biosciences Up After $220 Piper Sandler Call—Key Level for DRUG Traders

Bright Minds Biosciences Inc. shares climbed on Wednesday after Piper Sandler boosted its price target on the company. DRUG closed at $82.78 on the Nasdaq, jumping 11.1% from Tuesday’s $74.54 finish. The new target puts the stock in focus for Thursday’s U.S. trading. That’s relevant since U.S. markets were still closed at the dateline. Regular hours at Nasdaq are 9:30 a.m. to 4:00 p.m. Eastern, with pre-market hours ahead of that. So Wednesday’s close was the last official mark.
May 21, 2026
Bio-Techne Shares Bounce, Investors Eye a Key Risk

Bio-Techne Shares Bounce, Investors Eye a Key Risk

Bio-Techne Corp is coming into Thursday’s U.S. session with shares up for three days. The stock finished Wednesday at $46.70, gaining 2.7%. As of the dateline, the regular Nasdaq session was still ahead. Nasdaq’s standard hours run 9:30 a.m. to 4:00 p.m. Eastern. Its next scheduled May 2026 closing is Memorial Day on May 25. BIO-TECHNE STAYS UNDER PRESSURE AS RALLY FIZZLES The rally is still a repair move right now. Bio-Techne is well under its January peak, with investors cutting the stock this month after fiscal Q3 sales came in below forecasts.
May 21, 2026
Aterian Moves Lower Pre-Market With $18 Million Ballot Ahead

Aterian Moves Lower Pre-Market With $18 Million Ballot Ahead

Aterian Inc. shares slipped before the bell Thursday. Investors continue to weigh a planned asset sale and new financing that could change the shape of the consumer-products group. The stock traded at $1.15, off 2.5% ahead of Nasdaq’s 9:30 a.m. ET open. Aterian is in the spotlight now not because of a product launch or earnings. The focus is on the small-cap company’s push to win shareholder support for a deal that could transfer its main brands and change control. Market data puts Aterian’s valuation at around $12.8 million.
May 21, 2026
Vanda Shares Move in Pre-Market Ahead of Nereus and Bysanti Data

Vanda Shares Move in Pre-Market Ahead of Nereus and Bysanti Data

Vanda Pharmaceuticals VNDA dipped in early premarket trade Thursday, off 0.5% at $6.15 before the bell. Shares closed at $6.18 on Wednesday, when the stock climbed 3.2%. Investors looked at the drugmaker’s latest investor meetings and balanced that with concerns about costs for new product launches. Vanda is shifting focus from regulatory wins to showing product sales now. The Washington company recently launched Nereus for motion-induced vomiting and Bysanti for schizophrenia and acute bipolar I disorder, putting them in a lineup with Fanapt, Hetlioz and Ponvory.
May 21, 2026
LIMN Stock Rises in Pre-Market on Liminatus InnocsAI Deal News

LIMN Stock Rises in Pre-Market on Liminatus InnocsAI Deal News

Liminatus Pharma shares moved higher in premarket trading Thursday after the cancer drug company said it plans to buy InnocsAI LLC, a private oncology platform. The deal would sharply increase Liminatus’ share count. LIMN traded at $0.2844 in premarket as of 8:04 a.m. EDT, a jump of 51.4% from the Wednesday close at $0.1878, StockAnalysis said. Premarket trading happens before the main Nasdaq hours.
May 21, 2026
Aimei Health: Nasdaq Sends AFJK 60-Day Notice

Aimei Health: Nasdaq Sends AFJK 60-Day Notice

Aimei Health Technology Co., Ltd is facing a new Nasdaq compliance issue as of Thursday’s U.S. session after the blank-check firm confirmed its March-quarter report was not filed on time. AFJK isn’t a regular healthcare stock right now. It’s a blank-check company set up to buy or merge with another firm. That means listing status, timing on any deal, and how much cash is in its trust are bigger factors than typical revenue trends.
May 21, 2026
NMFC Stock Moves Higher Ahead of Open as New Mountain Finance Buyback Faces Private Credit Trial

NMFC Stock Moves Higher Ahead of Open as New Mountain Finance Buyback Faces Private Credit Trial

New Mountain Finance Corp. is coming into Thursday’s Nasdaq open after gaining 2.1%, but the stock is still trading well under its latest book value. Shares finished Wednesday at $8.12. Nasdaq’s regular session is 9:30 a.m. to 4 p.m. Eastern, and premarket starts at 4 a.m. Discount is the main story now. NMFC last reported net asset value at $10.92 per share as of March 31, which puts the shares trading about 26% below NAV. Management has room with the buyback to create value, but investors are still pricing NMFC as a risk trade and not only for its income.
May 21, 2026
Neurogene Trades Around $27 With Street Watching Rett Data Test Midyear

Neurogene Trades Around $27 With Street Watching Rett Data Test Midyear

Neurogene Inc. shares barely moved in premarket trading on Nasdaq Thursday. Investors looked past new disclosures and kept their eyes on the upcoming clinical milestone for NGN-401, the lead gene therapy for Rett syndrome. The stock finished Wednesday at $26.95, gaining 7 cents, or 0.3%. It traded in a range from $26.50 to $28.08. Broader markets rallied too, with the Nasdaq Composite adding 1.5% and the Russell 2000 up 2.6% on Wednesday.
May 21, 2026
GrowHub at 33 Cents Faces Nasdaq Deadline Pressure

GrowHub at 33 Cents Faces Nasdaq Deadline Pressure

The GrowHub Limited’s shares stayed around 33 cents in premarket Nasdaq trading Thursday. That leaves the Singapore-based traceability firm still under a major Nasdaq minimum and less than two weeks from its June 1 deadline to meet compliance. TGHL last traded at $0.325, about 0.6% higher than its last close. Why price is in focus now: Nasdaq warned the company in December after its Class A shares stayed under the $1 minimum bid for 30 straight sessions, GrowHub said in its May 15 annual filing. That $1 mark is what a stock needs to close at to stay listed, according to the exchange.
May 21, 2026
ARKR Investors Wait on $24 Million Bryant Park Renewal

ARKR Investors Wait on $24 Million Bryant Park Renewal

Ark Restaurants Corp. last traded at $6.68 ahead of Thursday’s Nasdaq open, valuing the company near $24.1 million. Investors are still weighing soft sales and the ongoing battle over Ark’s Bryant Park sites in Manhattan. Robinhood showed volume at 916 shares, while the average is 2,440, pointing again to ARKR’s status as a thinly traded micro-cap. The timing is key here. Nasdaq’s normal hours are 9:30 a.m. to 4 p.m. Eastern, with pre-market trading kicking off at 4 a.m. According to its 2026 holiday schedule, the exchange won’t close again for a U.S. holiday until Memorial Day on May 25, skipping Thursday. So the stock gets two more regular sessions before a long weekend to trade on the company’s latest
May 21, 2026
XPEL Shares Climb on $110 Million Supply Move, Focus on San Antonio and China Margins

XPEL Shares Climb on $110 Million Supply Move, Focus on San Antonio and China Margins

XPEL jumped 4.5% Wednesday after the company said it is targeting about $110 million for manufacturing and supply-chain growth and also gave new details on financing tied to its San Antonio base. Shares finished at $45.21, valuing the Nasdaq-traded company near $1.25 billion. Timing is key here. XPEL is shifting from mostly asset-light and using a lot of third-party manufacturing to taking tighter control of production, quality, and logistics. The company still aims for operating margins in the mid-20% range by 2028. Operating margin shows profit from operations as a slice of revenue.
May 21, 2026
AREC Stock Jumps as American Resources’ Rare-Earth Pivot Gets a 10-K Test

AREC Stock Jumps as American Resources’ Rare-Earth Pivot Gets a 10-K Test

American Resources Corp shares last traded unchanged at $2.14 in Thursday premarket dealings, the early session before the 9:30 a.m. New York open, after closing up 10.3% on Wednesday as investors weighed a delayed annual report and a cleaner rare-earth strategy. U.S. regular trading had not opened; Nasdaq’s 2026 calendar lists Memorial Day, May 25, as the next scheduled market closure. The filing matters now because it removes part of a compliance overhang. Nasdaq told American Resources on April 24 that it was not in compliance with Listing Rule 5250 because it had not filed its 2025 Form 10-K, an annual report with audited accounts and risk disclosures; the notice had no immediate effect on the stock’s listing or trading.
May 21, 2026
Flexsteel Faces Key Session After 3.5% Stock Gain

Flexsteel Faces Key Session After 3.5% Stock Gain

Flexsteel Industries shares are up 3.5% going into Thursday’s regular session. Management is set to meet investors later Thursday, putting the company’s big buyback and margins in the spotlight again. Flexsteel Industries, Inc. ended Wednesday at $55.24, gaining 3.52%. The stock hit $55.54 during the session, with 43,376 shares traded, according to LSEG data posted on the company’s investor site. Sidoti has Flexsteel set to present Thursday from 2:30 p.m. to 3:00 p.m. EDT.
May 21, 2026
LivePerson Stock Alert: LPSN Rebounds as SoundHound Deal and Insider Filings Put Shares on Watch

LivePerson Stock Alert: LPSN Rebounds as SoundHound Deal and Insider Filings Put Shares on Watch

LivePerson Inc. shares go into Thursday’s U.S. pre-market with the stock back at $2.07, after a modest bounce that did not erase Tuesday’s fall. The Nasdaq-listed customer-engagement software company closed up 3.0% Wednesday on volume of 97,378 shares, LivePerson investor data showed. This matters now because LPSN is trading less like a routine software earnings story and more like a pending deal stock. Nasdaq’s pre-market system was open in New York, regular trading runs from 9:30 a.m. to 4:00 p.m. ET, and Nasdaq’s 2026 holiday schedule lists Memorial Day, May 25, not Thursday, as the next full U.S. market closure.
May 21, 2026
1 31 32 33 34 35 220